A&O Shearman
We are only able to display limited information for this firm. We display more complete information for all of the following firms:
A&O Shearman has a comprehensive healthcare and life sciences offering, allowing the team to advise clients across the pharmaceuticals, finance, biotech, medtech and healthcare sectors. Typical mandates for the team include M&A transactions, infringement lawsuits, patent litigation and regulatory data protection advice. Laëtitia Bénard, who spearheads the practice, is an experienced litigator, well regarded in the market for her expertise in handling multi-jurisdictional and national patent disputes for major pharmaceutical companies. Charles Tuffreau brings strong expertise in validity and infringement issues, advising clients across the full remit of cross-border litigation and preliminary injunction proceedings.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
- ‘Laëtitia Bénard communicates clearly and always takes different perspectives into consideration. She works relentlessly on a given task.’
- ‘The team provide very clear advice on possible outcomes, and are able to switch strategy if new reasonable arguments appear.’
Key clients
- Bayer
- Organon
Work highlights
Representing a global pharmaceutical and healthcare company in the protection of its supplementary protection certificate (SPC) for the combination of sitagliptin and metformin, addressing challenges posed by multiple generic companies seeking to launch their generic products.